146 related articles for article (PubMed ID: 11036378)
21. The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer.
Temple LK; Bacik J; Savatta SG; Gottesman L; Paty PB; Weiser MR; Guillem JG; Minsky BD; Kalman M; Thaler HT; Schrag D; Wong WD
Dis Colon Rectum; 2005 Jul; 48(7):1353-65. PubMed ID: 15868235
[TBL] [Abstract][Full Text] [Related]
22. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
Kapiteijn E; Putter H; van de Velde CJ;
Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
[TBL] [Abstract][Full Text] [Related]
23. Surgery for local recurrence of rectal cancer.
Heriot AG; Tekkis PP; Darzi A; Mackay J
Colorectal Dis; 2006 Nov; 8(9):733-47. PubMed ID: 17032318
[TBL] [Abstract][Full Text] [Related]
24. Population-based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer.
Manfredi S; Benhamiche AM; Meny B; Cheynel N; Rat P; Faivre J
Br J Surg; 2001 Sep; 88(9):1221-7. PubMed ID: 11531871
[TBL] [Abstract][Full Text] [Related]
25. Rectal cancer: Preoperative versus postoperative irradiation as a component of adjuvant treatment.
Gunderson LL; Haddock MG; Schild SE
Semin Radiat Oncol; 2003 Oct; 13(4):419-32. PubMed ID: 14586831
[TBL] [Abstract][Full Text] [Related]
26. Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
Meyerhardt JA; Tepper JE; Niedzwiecki D; Hollis DR; Schrag D; Ayanian JZ; O'Connell MJ; Weeks JC; Mayer RJ; Willett CG; MacDonald JS; Benson AB; Fuchs CS
J Clin Oncol; 2004 Jan; 22(1):166-74. PubMed ID: 14701779
[TBL] [Abstract][Full Text] [Related]
27. Rectal cancer radiotherapy.
Ramsey S; Tepper JE
Cancer J; 2007; 13(3):204-9. PubMed ID: 17620771
[TBL] [Abstract][Full Text] [Related]
28. Quality assurance of surgery in gastric and rectal cancer.
Peeters KC; van de Velde CJ
Crit Rev Oncol Hematol; 2004 Aug; 51(2):105-19. PubMed ID: 15276175
[TBL] [Abstract][Full Text] [Related]
29. [Effect of total mesorectal excision and preoperative chemoradiotherapy on local recurrence in rectal cancer].
Wu AW; Gu J; Wang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):207-9. PubMed ID: 16721678
[TBL] [Abstract][Full Text] [Related]
30. Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands.
Vermaas M; Gosselink MP; Ferenschild FT; van den Aardweg E; Lont HE; Kemperman HW; van der Harst E; Tetteroo GW; Oostenbroek RJ; Dijkhuis CM; Eggermont AM; de Wilt JH
Eur J Surg Oncol; 2007 Sep; 33(7):862-7. PubMed ID: 17257804
[TBL] [Abstract][Full Text] [Related]
31. [Local tumor control and (disease-free) survival after surgery with pre- and intraoperative radiotherapy for primary non-resectable rectal carcinoma and local recurrence].
Mannaerts GH; Martijn H; Rutten HJ; Hanssens PE; Wiggers T
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1460-6. PubMed ID: 11503316
[TBL] [Abstract][Full Text] [Related]
32. [Contribution of cancer registries to the evaluation of cancer treatment: on the example of rectal cancer].
Maurel J; Launoy G; Grosclaude P; Petit T; Gignoux M; Faivre J
Ann Chir; 1996; 50(10):865-74. PubMed ID: 9183871
[TBL] [Abstract][Full Text] [Related]
33. Outcome of postoperative treatment for rectal cancer UICC stage II and III in day-to-day clinical practice. Results from a retrospective quality control analysis in six institutions in North Bavaria (Germany).
Wulf J; Krämer K; van Aaken C; Dietzel F; Lucas D; Pfändner K; Schimpke T; Schulze W; Thiel HJ; Ziegler K; Flentje M
Strahlenther Onkol; 2004 Jan; 180(1):5-14. PubMed ID: 14704839
[TBL] [Abstract][Full Text] [Related]
34. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
[TBL] [Abstract][Full Text] [Related]
35. Preoperative radiotherapy improves outcome in recurrent rectal cancer.
Vermaas M; Ferenschild FT; Nuyttens JJ; Marinelli AW; Wiggers T; van der Sijp JR; Verhoef C; Graveland WJ; Eggermont AM; de Wilt JH
Dis Colon Rectum; 2005 May; 48(5):918-28. PubMed ID: 15785886
[TBL] [Abstract][Full Text] [Related]
36. Quality of treatment in routine care in a population sample of rectal cancer patients.
Engel J; Kerr J; Eckel R; Günther B; Heiss M; Heitland W; Jauch KW; Siewert JR; Hölzel D
Acta Oncol; 2005; 44(1):65-74. PubMed ID: 15848908
[TBL] [Abstract][Full Text] [Related]
37. [The surgeon as a cost factor. Cost analysis exemplified by surgical treatment of rectal carcinoma].
Meyer T; Merkel S; Pfaffenberger M; Hohenberger W
Chirurg; 2002 Feb; 73(2):167-73. PubMed ID: 11974481
[TBL] [Abstract][Full Text] [Related]
38. Multidisciplinary treatment of resectable rectal cancer.
Ayala DN; Russo SM; Blackstock AW
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):383-94. PubMed ID: 19673625
[TBL] [Abstract][Full Text] [Related]
39. Impact of a surgical training programme on rectal cancer outcomes in Stockholm.
Martling A; Holm T; Rutqvist LE; Johansson H; Moran BJ; Heald RJ; Cedermark B
Br J Surg; 2005 Feb; 92(2):225-9. PubMed ID: 15609382
[TBL] [Abstract][Full Text] [Related]
40. [Recurrence of rectal cancer--treatment in Norwegian hospitals].
Bentzen AG; Vonen B; Wiig JN; Balteskard L
Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3102-5. PubMed ID: 18049504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
